Integral Derivatives’s VivoSim Labs VIVS Stock Holding History

Integral Derivatives’s Portfolio VIVS Stock Details VIVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-69	Closed	-$22K	–	1063
2017 Q4	$22K	Buy	+69	New	+$25.6K	﹤0.01%	1089

Other funds holding VIVS

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Integral Derivatives's VIVS Position: Q1 2018 in Review

Integral Derivatives sold out of VivoSim Labs (VIVS) in Q1 2018, closing a stake of 69 shares — an estimated $22K sold.

Integral Derivatives first reported a position in VIVS in Q4 2017 and held it in 1 quarter. The position peaked at $22K in Q4 2017. 105 funds tracked by Wall St. Rank hold VIVS as of Q1 2018.

Integral Derivatives reported no remaining VivoSim Labs position as of Q1 2018 after selling out during the quarter.
Integral Derivatives sold 69 VivoSim Labs shares in Q1 2018, an estimated $22K.
Integral Derivatives first reported a position in VivoSim Labs in Q4 2017 and held it in 1 quarter.
Integral Derivatives's VivoSim Labs position peaked at $22K in Q4 2017.
105 funds tracked by Wall St. Rank held VivoSim Labs as of Q1 2018.

Based on Integral Derivatives's 13F filing for Q1 2018, filed 19 Apr 2018.